HA

Hospital Arnau de Vilanova at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Hospital Arnau de Vilanova takes part in 3 sessions at ESMO 2026 in Madrid. Its program centres on metastatic breast cancer, with a focus on tailoring treatment decisions to the individual patient. It also covers first-line care for metastatic triple-negative breast cancer and personalised maintenance treatment for HER2-positive disease.

OrganizationESMO 2026 Attendance
HA
Hospital Arnau de Vilanova
Valencia, Spain
Cancer centre & hospital
Public university hospital in Valencia, Spain, within the Spanish national health system.
Satellite
Sat Oct 24
13:40–14:05
Beyond efficacy curves: Putting patients first in 1L mTNBC: A Case based perspective
Gilead and Kite Oncology - Sacituzumab Govitecan (SG), new backbone for 1L mTNBC, regardless of PD-L1 status. Changing the 1L paradigm: what the new indication approvals mean for everyday clinical practice
Breast cancer
Satellite
Sun Oct 25
18:30–20:00
Satellite
Sun Oct 25
18:30–18:33
Welcome and Introduction
Pfizer Oncology - Metastatic Breast Cancer: Individualised Decision- Making in Focus
Breast cancer
Satellite
Sun Oct 25
18:33–18:38
The Expert View: Rethinking Clinical Assumptions in MBC
Pfizer Oncology - Metastatic Breast Cancer: Individualised Decision- Making in Focus
Breast cancer
Satellite
Sun Oct 25
18:38–19:33
Clinical Snapshots: Applying an Individualised Approach in MBC
Pfizer Oncology - Metastatic Breast Cancer: Individualised Decision- Making in Focus · with Dana-Farber Cancer Institute, Institut de Cancérologie de l'Ouest, University Medical Center Hamburg-Eppendorf
Breast cancer
Satellite
Sun Oct 25
19:33–19:48
Redefining the Future: Personalised Maintenance Strategies in HER2+ MBC
Pfizer Oncology - Metastatic Breast Cancer: Individualised Decision- Making in Focus · with Dana-Farber Cancer Institute, Institut de Cancérologie de l'Ouest, University Medical Center Hamburg-Eppendorf
Breast cancer
Satellite
Sun Oct 25
19:48–19:58
Ask the Expert: Panel Discussion and Audience Q&A
Pfizer Oncology - Metastatic Breast Cancer: Individualised Decision- Making in Focus · with Dana-Farber Cancer Institute, Institut de Cancérologie de l'Ouest, University Medical Center Hamburg-Eppendorf
Breast cancer
Chair
Mon Oct 26
10:15–11:45
Rapid oral 2: Breast cancer, advanced stage
with Memorial Sloan Kettering Cancer Center, Peter MacCallum Cancer Centre
Breast cancer
Abstract
Mon Oct 26
11:05–11:17
Invited Discussant 1767RO, 1768RO and LBA49
Rapid oral 2: Breast cancer, advanced stage
Breast cancer

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Hospital Arnau de Vilanova

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction